Drreddys Laboratories | Passifs Courants



Current Liabilities Changement Date
ANI Pharmaceuticals USD 236.83M 35.02M 2025-06
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bayer EUR 29.78B 1.82B 2025-06
Canopy Growth CAD 97.02M 184.27M 2024-12
Cipla INR 54.84B 291.6M 2025-03
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Drreddys Laboratories INR 131.95B 2.65B 2024-12
GlaxoSmithKline GBP 20.38B 453M 2025-06
Hikma Pharmaceutical USD 1.98B 598M 2024-12
Lonza CHF 3.58B 970M 2024-12
Novartis USD 31.71B 95M 2025-06
Pacira USD 313.16M 1.57M 2025-06
Prestige Brands USD 109.67M 3.04M 2025-06
Richter Gedeon HUF 175.24B 34.29B 2024-12
Sun Pharmaceuticals INR 181.94B 9.39B 2025-03
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
Teva Pharmaceutical Industries USD 11.86B 704M 2025-06


Drreddys Laboratories Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.